SCHEMBL20907753

SCHEMBL20907753

C=C/C=C\C(CC)=C(/C)CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22627609 0.85
SCHEMBL14220688 0.80 TSHR (0.34)
SCHEMBL18513846 0.78
SCHEMBL22622820 0.78 ALDH1A1 (0.35)
SCHEMBL18544760 0.78 TSHR (0.34)
SCHEMBL20806087 0.76
SCHEMBL18752103 0.74
SCHEMBL20178005 0.74
SCHEMBL6888587 0.74
SCHEMBL27582696 0.73 ALDH1A1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10822370-B2 19-nor neuroactive steroids and methods of use thereof SAGE THERAPEUTICS, INC. (US) 2020-11-03 US disclosed
US-10561666-B2 Amido compounds as RORγt modulators and uses thereof THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2020-02-18 US disclosed
US-20190216895-A1 BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF LAUREN SCIENCES LLC (US) 2019-07-18 US disclosed
US-20190112331-A1 19-NOR NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF SAGE THERAPEUTICS, INC. 2019-04-18 US disclosed